Search

everythinglearnresearchcommunity

for

Search:↓

Isoflavone may help manage PCOS symptoms, but its effectiveness is uncertain.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

People with androgenic alopecia are more likely to have metabolic syndrome than healthy individuals.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

PCOS may start before birth, involves metabolic issues, and can be treated with drugs like metformin and lifestyle changes.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

Polycystic ovarian shape is a genetic sign of PCOS and its hormonal and metabolic features can be inherited.

Human hair follicles have a unique metabolism that changes between growth stages and may contribute to baldness.

Testosterone and dihydrotestosterone affect hair growth, and new techniques like the folliculogram help study it, but fully understanding hair growth is still complex.

Selenium might help with insulin resistance and cholesterol in PCOS, but more research is needed to confirm its benefits.

High Lipid Accumulation Product levels are linked to more hirsutism in women with Polycystic Ovary Syndrome.

PCOS is linked to diabetes and insulin resistance, and managing AGEs may help treat related symptoms.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

Rutin may help treat symptoms of polycystic ovary syndrome (PCOS) in rats.

Simvastatin may help manage symptoms in women with non-classic congenital adrenal hyperplasia by lowering cholesterol and certain hormone levels.

A low-starch/low-dairy diet may help overweight women with PCOS lose weight and improve metabolism, but more research is needed.

Women with Polycystic Ovary Syndrome have higher levels of the hormone ghrelin, which may be linked to the cause of the condition.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

Taking spironolactone and linestrenol for androgen excess can lead to lower bone density in young women.

Early balding in men is linked to metabolic syndrome, so screening is important for prevention.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

Metformin improves menstrual cycles and hormone levels in women with PCOS, mostly within the first 6 months.

Women with PCOS have lower adiponectin hormone levels and are more likely to have insulin resistance.

Women with PCOS have different levels of certain fats and proteins in their blood, which could help diagnose the condition.

Mutations in the CYP21A2 gene are not a major factor in causing PCOS.

Certain gene variations might help protect against insulin resistance and glucose intolerance in people with Polycystic Ovary Syndrome.

Acne and hair loss are not good indicators of hormone imbalance in PCOS, but excessive body hair is.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

Hair loss causes differ between men and women due to changes in hormone levels and inflammation-related pathways.